Medtronic MiniMed Insulin Pump RF Remote Control Vulnerability Advisory

Critical Vulnerability Information Vulnerability Overview Product: MiniMed 508 and MiniMed Paradigm Series insulin pumps Vulnerability Type: Potential remote control risk; attackers may alter insulin pump settings via radio frequency (RF) signals, leading to hypoglycemia or hyperglycemia. Impact: May cause serious health issues for patients, such as hypoglycemia or diabetic ketoacidosis. Affected Products Mitigation Measures All Patients: - Always keep the insulin pump and connected devices within your control. - Protect the serial number. - Pay attention to pump notifications, alarms, and warnings. - Immediately cancel any unexpected infusions and take appropriate action. - Monitor blood glucose levels and record results. - Avoid third-party accessories and unauthorized software. - Disconnect the CareLink software USB device from the computer when not used for data download. - Seek immediate medical help if experiencing severe hypoglycemia symptoms, diabetic ketoacidosis, or suspecting unauthorized changes to pump settings or infusion rates. US Patients: Medtronic recommends that current users of affected products discuss with their healthcare provider the option of switching to newer insulin pump models with enhanced cybersecurity protections, such as the MiniMed 770G insulin pump. Non-US Patients: Follow mitigation measures required by local regulations in your country/region.

Goal Reached Thanks to every supporter — we hit 100%!

Medtronic MiniMed Insulin Pump RF Remote Control Vulnerability Advisory